Terray's Jacob Berlin on The AI-Powered Future of Medicine
Terray Therapeutics CEO Jacob Berlin returns to Founded & Funded after three years to share how the company has scaled from an ambitious startup to an industry leader in AI-driven biotech. Learn how Terray's proprietary hardware combined with the world's largest chemistry data set is powering new discoveries in small molecule drug development.
Jacob also discusses how the company's $120M Series B fundraise will prepare their internal programs for clinical trials and further enhance their AI platform. He shares insights on where he sees the future of AI and drug design and dives into how…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.